BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11481652)

  • 21. Paratesticular sarcoma in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Studies I and II, 1973-1983.
    Raney RB; Tefft M; Lawrence W; Ragab AH; Soule EH; Beltangady M; Gehan EA
    Cancer; 1987 Nov; 60(9):2337-43. PubMed ID: 3440240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary tumor size predicts pathologic findings in the retroperitoneal lymph nodes in patients with paratesticular rhabdomyosarcoma.
    Alanee S; Holland B; Dynda D; Kamel O; Ganai S
    Virchows Arch; 2014 Dec; 465(6):697-701. PubMed ID: 25293343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of surgical excision in chest wall rhabdomyosarcoma: a report from the Children's Oncology Group.
    Hayes-Jordan A; Stoner JA; Anderson JR; Rodeberg D; Weiner G; Meyer WH; Hawkins DS; Arndt CA; Paidas C;
    J Pediatr Surg; 2008 May; 43(5):831-6. PubMed ID: 18485948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved outcome for patients with middle ear rhabdomyosarcoma: a children's oncology group study.
    Hawkins DS; Anderson JR; Paidas CN; Wharam MD; Qualman SJ; Pappo AS; Scott Baker K; Crist WM
    J Clin Oncol; 2001 Jun; 19(12):3073-9. PubMed ID: 11408504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Third Intergroup Rhabdomyosarcoma Study.
    Crist W; Gehan EA; Ragab AH; Dickman PS; Donaldson SS; Fryer C; Hammond D; Hays DM; Herrmann J; Heyn R
    J Clin Oncol; 1995 Mar; 13(3):610-30. PubMed ID: 7884423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group.
    Ferrari A; Bisogno G; Casanova M; Meazza C; Piva L; Cecchetto G; Zanetti I; Pilz T; Mattke A; Treuner J; Carli M
    J Clin Oncol; 2002 Jan; 20(2):449-55. PubMed ID: 11786573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
    Michalski JM; Meza J; Breneman JC; Wolden SL; Laurie F; Jodoin M; Raney B; Wharam MD; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1027-38. PubMed ID: 15234036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.
    Stewart RJ; Martelli H; Oberlin O; Rey A; Bouvet N; Spicer RD; Godzinski J; Stevens MC;
    J Clin Oncol; 2003 Mar; 21(5):793-8. PubMed ID: 12610176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
    Wolden SL; Anderson JR; Crist WM; Breneman JC; Wharam MD; Wiener ES; Qualman SJ; Donaldson SS
    J Clin Oncol; 1999 Nov; 17(11):3468-75. PubMed ID: 10550144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic retroperitoneal lymph node dissection for low-stage testicular cancer.
    Skolarus TA; Bhayani SB; Chiang HC; Brandes SB; Kibel AS; Landman J; Figenshau RS
    J Endourol; 2008 Jul; 22(7):1485-9. PubMed ID: 18613781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome, Treatment, and Treatment Failures in Patients Suffering Localized Embryonal Paratesticular Rhabdomyosarcoma: Results From the "Cooperative Weichteilsarkom Studiengruppe" Trials CWS-86, -91, -96, and -2002P.
    Seitz G; Fuchs J; Martus P; Klingebiel T; Leuschner I; Schuck A; Dantonello TM; Koscielniak E;
    Ann Surg; 2016 Dec; 264(6):1148-1155. PubMed ID: 27828824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population.
    Glaser AP; Bowen DK; Lindgren BW; Meeks JJ
    J Pediatr Urol; 2017 Apr; 13(2):223-224. PubMed ID: 28262537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?
    Arndt CA; Donaldson SS; Anderson JR; Andrassy RJ; Laurie F; Link MP; Raney RB; Maurer HM; Crist WM
    Cancer; 2001 Jun; 91(12):2454-68. PubMed ID: 11413538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Retroperitoneal lymph node assessment in pediatric paratesticular rhabdomyosarcoma].
    Guérin F; Martelli H
    Bull Cancer; 2020 Jun; 107(6):666-671. PubMed ID: 32303361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative approaches to retroperitoneal lymph node dissection for paratesticular rhabdomyosarcoma.
    Mansfield SA; Murphy AJ; Talbot L; Prajapati H; Maller V; Pappo A; Singhal S; Krasin MJ; Davidoff AM; Abdelhafeez A
    J Pediatr Surg; 2020 Dec; 55(12):2677-2681. PubMed ID: 32345499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What comprises appropriate therapy for children/adolescents with rhabdomyosarcoma arising in the abdominal wall? A report from the Intergroup Rhabdomyosarcoma Study Group.
    Beech TR; Moss RL; Anderson JA; Maurer HM; Qualman SJ; Breneman JC; Wiener ES; Crist WM
    J Pediatr Surg; 1999 May; 34(5):668-71. PubMed ID: 10359160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staging paratesticular rhabdomyosarcoma in the "as low as reasonably achievable" age: the case for PET-CT.
    Burnette JO; Klaassen Z; Hatley RM; Neunert CE; Williams H; Donohoe JM
    Urology; 2013 Jul; 82(1):220-3. PubMed ID: 23352374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Walterhouse DO; Pappo AS; Meza JL; Breneman JC; Hayes-Jordan A; Parham DM; Cripe TP; Anderson JR; Meyer WH; Hawkins DS
    Cancer; 2017 Jun; 123(12):2368-2375. PubMed ID: 28211936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extremity sarcomas: an analysis of prognostic factors from the Intergroup Rhabdomyosarcoma Study III.
    Andrassy RJ; Corpron CA; Hays D; Raney RB; Wiener ES; Lawrence W; Lobe TE; Bagwell C; Maurer HM
    J Pediatr Surg; 1996 Jan; 31(1):191-6. PubMed ID: 8632278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group.
    Lawrence W; Anderson JR; Gehan EA; Maurer H
    Cancer; 1997 Sep; 80(6):1165-70. PubMed ID: 9305719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.